# Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

> **NCT00727129** · PHASE3 · COMPLETED · sponsor: **Upsher-Smith Laboratories** · enrollment: 495 (actual)

## Conditions studied

- Postmenopausal Symptoms

## Interventions

- **DRUG:** Divigel

## Key facts

- **NCT ID:** NCT00727129
- **Lead sponsor:** Upsher-Smith Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 495 (ACTUAL)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727129, "Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00727129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*